O’Mahony, Denis http://orcid.org/0000-0003-2236-5222
Cherubini, Antonio
Guiteras, Anna Renom
Denkinger, Michael
Beuscart, Jean-Baptiste
Onder, Graziano
Gudmundsson, Adalsteinn
Cruz-Jentoft, Alfonso J.
Knol, Wilma
Bahat, Gülistan
van der Velde, Nathalie
Petrovic, Mirko
Curtin, Denis
Funding for this research was provided by:
University College Cork
Article History
Received: 10 January 2023
Accepted: 31 March 2023
First Online: 31 May 2023
Change Date: 16 June 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s41999-023-00812-y
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of study, formal consent is not required.
: In the preparation of STOPP/START criteria version 3, the authors have made every effort to ensure that all criteria as presented are accurate and evidence based. However, any and all decisions taken by prescribers on the initiation or avoidance of drugs or drug classes referred to in STOPP/START criteria version 3 are entirely the responsibility of the prescriber. We also emphasize that in the case of certain STOPP/START version 3 criteria, the evidence base for the criteria may change over time. For this reason, we recommend caution to prescribers to take account of the current evidence base relating to all drugs and medications referred to in individual STOPP/START version 3 criteria.